Stay updated on KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial

Sign up to get notified when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T15:58:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-06T09:35:36.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-30T04:35:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    1.0%
    Check dated 2025-05-23T01:34:20.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The study of KPT-8602 in participants with relapsed/refractory cancer indications has been completely removed from the page.
    Difference
    0.3%
    Check dated 2025-05-15T20:00:14.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-05-01T06:04:22.000Z thumbnail image

Stay in the know with updates to KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.